Pharnext SA (OTCMKTS:PNEXF – Get Free Report)’s stock price was up 399,999,900% during mid-day trading on Monday . The company traded as high as $400.00 and last traded at $400.00. Approximately 16,660 shares changed hands during trading, an increase of 3,748% from the average daily volume of 433 shares. The stock had previously closed at $0.00.
Pharnext Stock Performance
The firm has a 50-day moving average of $400.00 and a 200 day moving average of $400.00.
About Pharnext
Pharnext SA, a clinical-stage biopharmaceutical company, engages in the development of therapies for neurodegenerative diseases with high unmet medical needs. Its products include PXT3003, a novel fixed-dose synergistic combination of baclofen, naltrexone, and sorbitol formulated that is in Phase III clinical trials for the treatment of Charcot-Marie-tooth disease type 1A; and PXT864 to treat amyotrophic lateral sclerosis.
Recommended Stories
- Five stocks we like better than Pharnext
- There Are Different Types of Stock To Invest In
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- 3 REITs to Buy and Hold for the Long Term
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Receive News & Ratings for Pharnext Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharnext and related companies with MarketBeat.com's FREE daily email newsletter.
